Endo International Management
Management criteria checks 3/4
Endo International's CEO is Blaise Coleman, appointed in Dec 2016, has a tenure of 7.42 years. total yearly compensation is $12.85M, comprised of 7.6% salary and 92.4% bonuses, including company stock and options. directly owns 0.18% of the company’s shares, worth $253.23. The average tenure of the management team and the board of directors is 4.8 years and 7 years respectively.
Key information
Blaise Coleman
Chief executive officer
US$12.8m
Total compensation
| CEO salary percentage | 7.6% |
| CEO tenure | 7.4yrs |
| CEO ownership | 0.2% |
| Management average tenure | 4.8yrs |
| Board average tenure | 7yrs |
Recent management updates
Recent updates
Endo creditors looking at putting company up for sale through bankruptcy - Bloomberg
Aug 16Endo International sees 23% rise on 3x higher than normal volume
Aug 03Endo outperforms defying bankruptcy fears and generic entry
Jul 25Endo weighs bankruptcy filing without opioid settlement - WSJ
Jul 12Endo International cools off, giving back some of its 85% Tuesday gain
Jun 29Endo: Stick A Fork In It
May 10Endo: About As Bad As It Gets
Mar 07Endo: FDA Approves Generic Form Of Vasostrict Creating Headwind Into Next Year
Dec 16Endo: A Win In California But Equity Value Still A Question
Nov 02Endo International: Loses Vasostrict Trial
Aug 31Endo International: Hires Restructuring Advisor
Aug 20Endo International: All About Ongoing Litigation
Aug 07Endo: Appellate Court Denies Request To Postpone Damages Trial Might Be End O' The Road
Jul 15Endo International: Bankruptcy Seems Like The Only Practical Option
Jun 30Endo International wins FDA approval for Micafungin new formulation
Jun 17Endo International plc 2021 Q1 - Results - Earnings Call Presentation
May 07Radius Health partners with Endo unit for abaloparatide in Canada
Jan 05CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$2b |
| Sep 30 2023 | n/a | n/a | -US$252m |
| Jun 30 2023 | n/a | n/a | -US$942m |
| Mar 31 2023 | n/a | n/a | -US$3b |
| Dec 31 2022 | US$13m | US$978k | -US$3b |
| Sep 30 2022 | n/a | n/a | -US$3b |
| Jun 30 2022 | n/a | n/a | -US$3b |
| Mar 31 2022 | n/a | n/a | -US$681m |
| Dec 31 2021 | US$29m | US$913k | -US$569m |
| Sep 30 2021 | n/a | n/a | US$129m |
| Jun 30 2021 | n/a | n/a | US$109m |
| Mar 31 2021 | n/a | n/a | US$137m |
| Dec 31 2020 | US$7m | US$829k | US$247m |
| Sep 30 2020 | n/a | n/a | -US$102m |
| Jun 30 2020 | n/a | n/a | -US$75m |
| Mar 31 2020 | n/a | n/a | -US$190m |
| Dec 31 2019 | US$4m | US$612k | -US$361m |
| Sep 30 2019 | n/a | n/a | -US$418m |
| Jun 30 2019 | n/a | n/a | -US$522m |
| Mar 31 2019 | n/a | n/a | -US$477m |
| Dec 31 2018 | US$3m | US$569k | -US$962m |
| Sep 30 2018 | n/a | n/a | -US$968m |
| Jun 30 2018 | n/a | n/a | -US$921m |
| Mar 31 2018 | n/a | n/a | -US$2b |
| Dec 31 2017 | US$4m | US$546k | -US$1b |
Compensation vs Market: Blaise's total compensation ($USD12.85M) is above average for companies of similar size in the US market ($USD674.46K).
Compensation vs Earnings: Blaise's compensation has been consistent with company performance over the past year.
CEO
Blaise Coleman (49 yo)
7.4yrs
Tenure
US$12,849,847
Compensation
Mr. Blaise A. Coleman serves as President, Chief Executive Officer and Director of Endo Inc. Mr. Blaise serves as President, Chief Executive Officer and Director at Endo International plc since March 06, 2...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 7.4yrs | US$12.85m | 0.18% $ 253.2 | |
| Executive VP | 9yrs | US$4.25m | 0.15% $ 210.7 | |
| Executive Vice President of Global Research & Development | 2.3yrs | US$6.36m | no data | |
| Executive VP & CFO | 4.2yrs | US$7.98m | no data | |
| VP, Controller & Chief Accounting Officer | no data | no data | no data | |
| Senior VP of Information Technology & Chief Information Officer | 1.9yrs | no data | no data | |
| Senior Vice President of Investor Relations & Corporate Affairs | 5.8yrs | no data | no data | |
| Senior VP & Chief Compliance Officer | 6.1yrs | no data | no data | |
| Chief Human Resources Officer | 4.8yrs | no data | no data | |
| Executive VP & President of Global Commercial Operations | 7.4yrs | US$7.78m | no data | |
| Head of Endo Ventures Limited & Senior VP of Global Supply Chain | 3.5yrs | no data | no data | |
| Global Head of Quality & Compliance | 1.9yrs | no data | no data |
4.8yrs
Average Tenure
54yo
Average Age
Experienced Management: ENDP.Q's management team is considered experienced (4.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4.2yrs | US$12.85m | 0.18% $ 253.2 | |
| Independent Chairman | 4.3yrs | US$840.00k | 0.016% $ 22.9 | |
| Independent Director | 10.3yrs | US$625.00k | 0.15% $ 213.3 | |
| Independent Director | 10.3yrs | US$625.00k | 0.042% $ 59.3 | |
| Independent Director | 9.8yrs | US$505.00k | 0.043% $ 60.0 | |
| Independent Director | 3.3yrs | US$480.00k | 0.011% $ 14.9 | |
| Independent Director | 10.3yrs | US$505.00k | 0.047% $ 65.8 | |
| Independent Non-Executive Director | 3.8yrs | US$480.00k | 0.014% $ 19.7 |
7.0yrs
Average Tenure
61yo
Average Age
Experienced Board: ENDP.Q's board of directors are considered experienced (7 years average tenure).